Early intervention for bladder disease means preserving function and improving the odds.
A bladder tumour diagnosis demands action, not delay. Whether the situation calls for endoscopic tumour removal or complete bladder removal with urinary reconstruction, timing matters — particularly for muscle-invasive disease where progression risk increases with every week of delay. Thailand's urology centres deliver the full range of bladder surgery at JCI-accredited hospitals, with multidisciplinary oncology support and substantially shorter referral pathways.
Free, no-obligation — you pay the hospital directly with no markup.
Bladder surgery ranges from minimally invasive endoscopic resection of early tumours to complete bladder removal with urinary diversion for invasive cancer. The approach depends on tumour stage, grade, and location — determined by cystoscopy, biopsy, and cross-sectional imaging.
TURBT (transurethral resection of bladder tumour) is both diagnostic and therapeutic for non-muscle-invasive disease. Radical cystectomy — with either an ileal conduit or neobladder reconstruction — is the definitive treatment for muscle-invasive cancer. Thailand's urology centres handle both ends of this spectrum with fellowship-trained surgical teams and integrated pathology.
Bladder cancer treatment is time-sensitive — particularly muscle-invasive disease where delays in surgical treatment correlate with worse outcomes. Thailand eliminates the referral delays common in public healthcare systems.
Subspecialist
Fellowship-Trained Urological Oncologists
Our partner surgeons specialise in urological cancer surgery — not generalists handling occasional bladder cases. This subspecialisation matters for complex cystectomy and reconstruction.
50–70%
Significant Cost Savings
Same cystoscopic equipment, same robotic platform, same pathology standards. The savings reflect lower operating costs in Thailand, not lower surgical quality.
Weeks
Faster Treatment Timelines
Cystoscopy, biopsy, staging, and definitive surgery can all happen within a single two-to-three-week trip — not months of sequential referrals and appointments.
Integrated
Multidisciplinary Oncology Support
Pathology, radiology, medical oncology, and stoma care all coordinated under one roof. Treatment decisions happen in real time rather than across weeks of fragmented appointments.
We do not charge for our service — you pay the hospital directly with no markup. Here is what bladder surgery typically costs in Thailand and how it compares internationally.
Your Quote Will Include
Prices are approximate and vary by technique, surgeon, and hospital. Your personalised quote will include a full cost breakdown.
Bladder surgery in Thailand ranges from $4,000 to $7,200. TURBT sits at the lower end — it is a short endoscopic procedure with minimal hospital stay. Radical cystectomy with urinary diversion sits at the upper end, reflecting longer operative time, complex reconstruction, and extended hospital admission.
The total covers the surgeon's fee, anaesthesia, operating theatre, hospital stay, cystoscopic and robotic equipment, pre-operative staging, pathology with detailed histological analysis, post-operative medications, stoma supplies if applicable, and follow-up. Pathology is a significant component for cancer cases.
The procedure type is the dominant factor. TURBT is a 30–60 minute day-case procedure. Radical cystectomy takes three to five hours with a hospital stay of seven to ten days. Whether the urinary diversion is an ileal conduit or a more complex neobladder also affects operative time and cost.
Pricing varies by the complexity and scope of the procedure. Typical ranges at our partner hospitals in Thailand:
Exact pricing is confirmed after your consultation and treatment plan are finalised.
Bladder surgery in Thailand costs 50–70% less than equivalent procedures in the US ($12,000–$24,000), Australia (A$10,000–A$20,000), and UK (£8,800–£18,000). For radical cystectomy — where the total bill is substantial — the absolute savings are significant.
The type of surgery is determined by tumour stage. Non-muscle-invasive disease is managed endoscopically. Muscle-invasive disease requires more extensive surgery. The staging biopsy is the critical first step.
A resectoscope passes through the urethra and shaves the tumour away under direct vision. No skin incision. Tissue is sent for detailed pathological staging. TURBT is both the primary diagnostic tool and the treatment for non-muscle-invasive bladder cancer. Re-resection at six weeks confirms complete removal.
Complete removal of the bladder — plus prostate in men, or uterus and part of the vagina in women — with pelvic lymph node dissection. A new urinary pathway is constructed, either an ileal conduit (external stoma bag) or neobladder (internal reservoir allowing natural voiding). The definitive treatment for muscle-invasive disease.
Removes the tumour-bearing segment of the bladder wall while preserving the rest of the organ. Suitable for a small subset of patients with a solitary, well-located tumour and no carcinoma in situ elsewhere. Preserves natural bladder function but requires careful patient selection.
Technique is determined by tumour stage and the planned extent of surgery. TURBT is performed endoscopically. Cystectomy can be open, laparoscopic, or robotic-assisted.
A resectoscope with an electrified wire loop resects the tumour under direct vision through the urethra. Systematic deep biopsies confirm whether muscle invasion is present. Blue-light cystoscopy using hexaminolevulinate improves detection of flat lesions. The technique is both diagnostic and therapeutic.
The da Vinci platform enables precise removal of the bladder and lymph nodes through small incisions with magnified 3D vision. Intracorporeal neobladder reconstruction — performing the entire urinary diversion inside the body without a large incision — is the most technically advanced option, available at leading Thai urology centres.
The traditional approach through a midline abdominal incision. Provides full direct access for complex cases, large tumours, or patients with extensive adhesions. Urinary diversion is constructed extracorporeally. Well-established technique with the most extensive long-term outcome data.
TURBT patients are typically discharged within 24–48 hours with a catheter for a short period. Cystectomy patients recover in hospital with catheter management, IV fluids, and pain control. Mild burning and blood-tinged urine are normal after TURBT. Early mobilisation begins promptly.
TURBT patients resume normal activities with mild precautions. Cystectomy patients continue in-hospital recovery — walking increases, diet advances, and drain management continues. Stoma education begins for ileal conduit patients. Neobladder patients learn the new voiding routine.
After discharge, outpatient follow-up monitors wound healing, stoma function, and pathology review. Light activities resume gradually. Fatigue is normal. The oncology team discusses adjuvant treatment if indicated by pathology.
Strength and stamina improve steadily. Cystectomy patients adjust to their urinary diversion. TURBT patients undergo follow-up cystoscopy at three months. A structured surveillance schedule is established before you return home.
TURBT patients can usually fly within seven to ten days. Cystectomy patients are typically cleared at fourteen to twenty-one days, once wound healing and urinary diversion function are confirmed. Stoma patients should be comfortable with stoma management before travelling. Compression stockings and adequate hydration are recommended.
TURBT patients return to desk work within a week. Cystectomy patients need four to six weeks before desk work and eight to twelve weeks before strenuous activity. Light walking starts immediately after both procedures. Pelvic floor exercises may be recommended after cystectomy.
TURBT results are immediate — the tumour is removed during the procedure. Pathology confirms depth of invasion and grade within a week, guiding further treatment. After cystectomy, urinary diversion function stabilises over weeks. Neobladder patients learn new voiding patterns over several months. Cancer surveillance follows a structured schedule.
The risk profile varies dramatically between TURBT and radical cystectomy. TURBT is a relatively minor endoscopic procedure. Cystectomy is major pelvic surgery with meaningful morbidity.
For TURBT, complications are uncommon and typically minor. For radical cystectomy, early complication rates of 30–50% are well documented in the published literature — most are manageable but the operation's morbidity profile should be understood honestly before proceeding.
Yes. Our partner hospitals are JCI-accredited with dedicated urology departments, robotic capability, and integrated oncology services. Fellowship-trained urological oncologists perform cystectomy at volumes consistent with outcome benchmarks. TURBT is a routine endoscopic procedure performed daily.
For cystectomy, choose a hospital with a dedicated urological oncology team — not a general surgeon doing occasional cystectomies. Ask about neobladder versus ileal conduit and which suits your anatomy and lifestyle. Optimise nutrition and fitness before travel. Stop smoking at least four weeks prior.
After TURBT for non-muscle-invasive disease, intravesical BCG or chemotherapy may be recommended to reduce recurrence. After cystectomy, adjuvant chemotherapy depends on final pathology. Surveillance cystoscopy after TURBT is essential — bladder cancer has a high recurrence rate, and early detection is key.
Bladder cancer surgery — particularly radical cystectomy — requires urological oncology subspecialisation. The surgeon's experience with urinary reconstruction is especially important.
Our partner hospitals have dedicated urological oncology teams with da Vinci robotic systems, blue-light cystoscopy capability, on-site pathology, and integrated medical oncology. They perform both TURBT and radical cystectomy at volume, with in-house ICU and stoma care support.
Our partner surgeons hold board certification with fellowship training in urological oncology. They perform radical cystectomy with both open and robotic approaches and are experienced in neobladder reconstruction — the most technically demanding urinary diversion.
Ask about cystectomy volume — outcomes improve with experience. Check whether the surgeon performs intracorporeal neobladder reconstruction if that option is relevant to your case. Confirm that the hospital has stoma care nurses to support ileal conduit patients through the adaptation period.
Bladder surgery results are measured by tumour clearance, urinary function, and long-term survival.
TURBT achieves complete tumour resection in the majority of non-invasive cases. Radical cystectomy for muscle-invasive disease offers five-year survival rates of 50–70% for organ-confined tumours. Neobladder patients typically achieve continent voiding. Ileal conduit patients adapt to stoma management within weeks.
For TURBT — tumour removal confirmed on pathology, with surveillance cystoscopy every three months initially. For cystectomy — cancer clearance assessed by pathology and ongoing imaging surveillance. Quality of life with urinary diversion is well studied and most patients report adaptation and good functional outcomes within months.
TURBT patients need seven to ten days. Cystectomy patients need two to three weeks. Here is how to plan.
TURBT patients need seven to ten days — consultation, cystoscopy with resection, pathology review, and follow-up. Cystectomy patients need fourteen to twenty-one days — pre-operative staging, surgery, seven to ten days of inpatient recovery, stoma education, and outpatient follow-up.
Your care coordinator arranges cystoscopy, surgery scheduling, pathology coordination, and follow-up. The quote covers surgeon fees, anaesthesia, facility, diagnostics, pathology, stoma supplies, and aftercare. Flights and accommodation are separate.
Bangkok is essential for bladder surgery recovery. TURBT patients need proximity for follow-up cystoscopy. Cystectomy patients need close access to the surgical team for stoma care, wound management, and any complication assessment. This is not a procedure to recover from at a distance.
Everything you need to know before your procedure
Patient Care Director
Last reviewed: March 25, 2026
Medical disclaimer: Content on this site is provided for informational purposes and should not be treated as medical advice. Outcomes, timelines, and eligibility differ from person to person. Consult a qualified medical professional before making any decisions about surgery or treatment.
Speak with our care coordinators for a free, no-obligation consultation and personalised quote.
Speak to Our TeamTestimonials
Real experiences from patients who travelled to Thailand for treatment.
Free & No Obligation
Tell us what you're considering and we'll come back with surgeon options, pricing, and a clear plan.
Get in Touch
Tell us about the procedure you are considering and a member of our team will respond within one working day with personalised guidance.
Loading your quote form...
